̖ | ˎƷQ | ͨ | a | Ҏ | λ | r |
121094 | е | }˾Ƭ | ˎ˾ | 4mg*10Ƭ | 208 | |
111028 | Wؐ | }˾עҺ | Rˎ˾ | 2ml:4mg | ֧ | 54.6 |
110693 | P | ˾עҺ | SmithKline Beecham Pharmaceuticals | 3mg/3ml | ֧ | 58.4 |
110392 | ͡ | }ͪעҺ | mˎ˾ | 4ml:8mg | ֧ | 48 |
111272 | е | }˾עҺ | ˎ˾ | 4ml:8mg | ֧ | 53.4 |
111622 | }˾עҺ | }˾עҺ | HtԺFϺϳˎɷ˾ | 4ml:8mg | ֧ | 53.4 |
110391 | ͡ | }ͪעҺ | mˎ˾ | 2ml:4mg | ֧ | 24 |
111273 | Џ͌ | ˾עҺ | GLAXO OPERATIONS UK LIMITED | 8mg/4ml*5֧ | 930 | |
111428 | fΨ | }ᰢ˾עҺ | 㽭fRˎI˾ | 10mg:2ml*6֧ | 940 | |
113106 | }˾עҺ | }˾עҺ | ̫OFĴ̫Oˎ˾ | 3ml:3mg | ֧ | 58.4 |
111027 | Wؐ | }˾עҺ | Rˎ˾ | 4ml:8mg | ֧ | 53.4 |
111967 | fΨ | }ᰢ˾עҺ | 㽭fRˎI˾ | 10mg:2ml | ֧ | 125 |
110767 | R | }˾ȻcעҺ | ؑcϿLˎ˾ | 50ml:3mg | ƿ | 63.1 |
130321 | Wն | }˾z | ɶAFɷ˾ˎS | 1mg*6 | 76.9 | |
111275 | }˾עҺ | ˎ˾ | 3ml3mg | ֧ | 85.7 | |
111216 | ِ | }˾עҺ | ˎIɷ˾ | 5ml:5mg | ֧ | 178 |
130715 | ŵ | }˾z | ɽ|Ͳ_ˎ˾ | 1mg*6 | 76.9 |
һ 1 һ β 퓴Σ1/1 50ƪ/ D |